Multinational firms opposing new drug pricing policy

The government’s controversial policies to cut drug pricing have been criticized by multinational drug manufacturer here as “rationale-lacking ones.”

The Korean Research-based Pharmaceutical Industry Association (KRPIA) said in a statement that multinational and domestic drug makers are both concerned by the potentially significant impact of the relentless price cuts on the prices and profit...